Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

UroGen Pharma (URGN) Debt Ratio: 2022-2025

Historic Debt Ratio for UroGen Pharma (URGN) over the last 4 years, with Sep 2025 value amounting to 0.66.

  • UroGen Pharma's Debt Ratio rose 63.71% to 0.66 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.66, marking a year-over-year increase of 63.71%. This contributed to the annual value of 0.43 for FY2024, which is 22.91% down from last year.
  • As of Q3 2025, UroGen Pharma's Debt Ratio stood at 0.66, which was up 12.43% from 0.59 recorded in Q2 2025.
  • UroGen Pharma's Debt Ratio's 5-year high stood at 1.03 during Q2 2023, with a 5-year trough of 0.35 in Q2 2024.
  • Moreover, its 3-year median value for Debt Ratio was 0.51 (2023), whereas its average is 0.58.
  • As far as peak fluctuations go, UroGen Pharma's Debt Ratio soared by 111.58% in 2023, and later tumbled by 66.33% in 2024.
  • Over the past 4 years, UroGen Pharma's Debt Ratio (Quarterly) stood at 0.72 in 2022, then dropped by 23.15% to 0.55 in 2023, then fell by 22.91% to 0.43 in 2024, then spiked by 63.71% to 0.66 in 2025.
  • Its last three reported values are 0.66 in Q3 2025, 0.59 for Q2 2025, and 0.49 during Q1 2025.